Praxis Precision Medicines announces Nasdaq Rule 5635(c)(4) inducement grants
Praxis Precision Medicines said its Board Compensation Committee approved inducement grants under Nasdaq Listing Rule 5635(c)(4) on September 1, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Praxis Precision Medicines announces Nasdaq Rule 5635(c)(4) inducement grants
Praxis Precision Medicines, Inc. announced inducement grants under Nasdaq Listing Rule 5635(c)(4).